This is an observational trial to estimate the incidence of deep vein thrombosis (DVT) in total knee replacement patients who received an intraoperative dose of tranexamic acid.
This study is anticipated to consist of 30 participants over 18 years of age scheduled for total knee arthroplasty at Sandoval Regional Medical Center with administered intraoperative tranexamic acid, who do not meet the exclusion criteria. The patients will be examined on postoperative day 1. Lower-extremity ultrasound will be used to screen for deep vein thrombosis (DVT). Incidence data for DVT will then be compared with the historical incidence rate at our institution for total knee arthroplasty without the use of tranexamic acid, which is approximately 12%. Patients found on screening to have deep vein thrombosis will be referred for appropriate care.
Study Type
OBSERVATIONAL
Enrollment
25
Intravenous or local administration of TXA, in any dosage
Sandoval Regional Medical Center
Rio Rancho, New Mexico, United States
Deep Vein Thrombosis
Incidence of deep vein thrombosis diagnosed by ultrasound scan on postoperative day 1
Time frame: One day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.